Risk stratification in primary sclerosing cholangitis: It's time to move on from replicating imperfection and break the glass ceiling

Affiliation

• ¹ National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, Centre for Liver and Gastroenterology Research, University of Birmingham, UK; Institute of Immunology and Immunotherapy, University of Birmingham, UK; Institute of Applied Health Research, University of Birmingham, UK; Liver Unit, University Hospitals Birmingham NHS Foundation Trust Queen Elizabeth, UK. Electronic address: p.j.trivedi@bham.ac.uk.